genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Novel Test Reportedly Detects Liver Disease Years Before It Can Become…
News
Alzheimer’s Progression May Hinge on Newfound Amyloid-Tau Link
Bristol-Myers Squibb
BMS Selling Celgene’s Otezla to Address FTC “Concerns” on $74B Deal
News
HDAC Inhibitor Found to Sensitize Cancers to Anti-PD1 Therapy
News
Microbiomes of Elite Athletes Contain Performance-Enhancing Bacteria
Insights
Insights
Single Cell Writing May Unlock CRISPR’s Full Potential
Tech Exclusives
Turning Drug Delivery Inside Out
Insights
Sartorius Takes a Single-Use Approach to Derive Value from Biomanufacturing
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Tech Exclusives
Not If. When: Metabolomics’ Impact in Cancer Treatments May Be Just…
A-Lists
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Insights
Top 50 NIH-Funded Institutions of 2019
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
June 2019 Vol. 39 No. 6
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Insights
Single Cell Writing May Unlock CRISPR’s Full Potential
Bristol-Myers Squibb
BMS Selling Celgene’s Otezla to Address FTC “Concerns” on $74B Deal
News
HDAC Inhibitor Found to Sensitize Cancers to Anti-PD1 Therapy
News
Microbiomes of Elite Athletes Contain Performance-Enhancing Bacteria
Magazine
All
Supplement
Tech Exclusives
Fighting the Dangerous Increase of Multidrug-Resistant Microbes
Tech Exclusives
The Microbiome: Here, There, and Everywhere
Commentary
New Vaccine Expected to Play Major Role in Battle against Malaria
Commentary
Lipidomics Enriches Multiomics
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Posters
A Web-Based Informatics Platform for PhysChem/ADME/Tox Property Predictions
GENcast
GENcast: Microbiome Research is More Than Just a Gut Reaction
Upcoming Webinars
Mind the Yap! Single-Cell Transcriptomes Reveal Drivers of Intestinal Regeneration
eBooks
Best Practices with an Agilent Parallel CE System
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Companies
Amgen
Amgen
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Amgen
Amgen Offers $167M for Cancer Collaboration Partner Nuevolution
Amgen
Amgen, Entera to Partner on Oral Drugs for Inflammatory Disease, Other “Serious” Illnesses
Amgen
Amgen Selects Second Cancer Target in 2-Year-Old Collaboration with Nuevolution
Amgen
Amgen, MD Anderson Launch Two Cancer Collaborations
Amgen
Amgen, Novartis Set to Launch Migraine Drug Aimovig Next Week after FDA Approval
Amgen
Federal Circuit Favors Novartis’ Sandoz over Amgen in Biosimilar “Patent Dance”...
Amgen
Amgen, Novartis Expand Alzheimer’s Collaboration with New Trial
Amgen
Amgen, CytomX Launch Up-to-$1.465B+ Cancer Immunotherapy Collaboration
Amgen
Amgen Delaying U.S. Launch of Humira Biosimilar in Settlement with AbbVie
Amgen
After FDA Approval, Amgen–Allergan Cancer Biosimilar Mvasi Faces Launch, Pricing Challenges
Amgen
FDA to Review BLA for Amgen-Novartis Migraine Prevention Treatment
Amgen
Amgen Licenses Ligand’s Captisol Technology for AML Candidate AMG 330
Amgen
FDA Rejects Amgen-UCB Osteoporosis Candidate Evenity
Amgen
EC Clears Sandoz’s Erelzi Biosimilar Etanercept Copy of Amgen’s Enbrel
Amgen
Supreme Court’s Sandoz–Amgen Decision Boosts Biosimilars
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
